Instruction for use: Cutivate

Active substance Fluticasone

ATX codeD07AC17 Fluticasone

Pharmacological group

Glucocorticosteroids

Nosological classification (ICD-10)

L20 Atopic dermatitis

Itchy atopic eczema, Common neurodermatitis, Allergic skin diseases, Allergic skin diseases of non-infectious etiology, Allergic skin diseases of non-microbial etiology, Allergic skin diseases, Allergic skin lesions, Allergic manifestations on the skin, Allergic dermatitis, Allergic diathesis, Allergic itching dermatosis, Allergic Skin Disease, Allergic skin irritation, Dermatitis allergic, Atopic dermatitis, Dermatosis allergic, Diathesis exudative, Skin Allergic Disease, Skin allergic reaction to medicinal and chemical preparations, Skin reaction to medication, Skin and allergic disease, Acute eczema, Chronic atopic dermatitis, Exudative diathesis, Itching allergic dermatosis

L20.0 Pochemuha Bienier

L21 Seborrheic dermatitis

Dermatitis seborrheic, Increased sebum separation, Seborrheic Eczema, Seborrheic dermatitis of the scalp, Seborrheic pyodermatitis, Seborrhea, Eczema seborrheic

L29 Itching

Itching with partial obstruction of the biliary tract, Dermatitis itchy, Dermatosis with persistent itching, Other itching dermatoses, Itching dermatoses, Itching allergic dermatosis, Itching dermatitis, Itching itch, Excruciating itching, Severe itching, Endogenous itching, Skin itching with dermatosis, Limited itching dermatitis, Itching of the skin, Itchy scalp, Itching eczema

L30.4 Erythematous intertrigo

Erythema of the buttocks, Dermatitis traumatic, Intertrigo, Interdigital intertrigo

L40 Psoriasis

Chronic psoriasis with diffuse plaques, Generalized psoriasis, Psoriasis of the scalp, Psoriasis of the scalp, Generalized form of psoriasis, Psoriasis dermatitis, Psoriasis complicated by erythroderma, Invalidative psoriasis, Isolated psoriatic plaque, Exfoliative psoriasis, Psoriatic Erythroderma, Psoriasis with eczematosis, Hyperkeratosis in psoriasis,Inverse psoriasis,Psoriasis eczematous, Dermatosis of psoriasis, Psoriasis of the genitals, Psoriasis with lesions of hairy areas of skin, Erythrodermal psoriasis, Chronic psoriasis of the scalp, Chronic psoriasis, Ordinary psoriasis, Refractory psoriasis, Kebner phenomenon, Scaly lichen

L43 Red Leaf Flat

Lishay Wilson, Erosive-ulcerative form of red flat lichen, Warty forms of red lichen, Red lichen, Flat lichen, Kebner phenomenon

L53 Other erythematous conditions

Variable erythrokeratodermia, Malignant exudative erythema, Erythema, Erythematous, Erythroderma, Erythema from diapers

L93.0 Discoid lupus erythematosus

Chronic discoid lupus erythematosus, Red discoid lupus, Discoid lupus, Discoid erythematosis

T78.4 Allergy, unspecified

Allergic reactions to insulin, Allergic reactions to insect stings, Allergic reactions similar to systemic lupus erythematosus, Allergic diseases, Allergic diseases of mucous membranes, Allergic diseases and conditions resulting from increased release of histamine, Allergic diseases of mucous membranes, Allergic symptoms, Allergic symptoms in the mucous membranes, Allergic reactions, Allergic reactions caused by insect bites, Allergic reactions, Allergic conditions, Allergic laryngeal edema, allergopathy, allergic conditions, Allergy, House dust allergy, Anaphylaxis, Cutaneous reactions to medications, Skin reaction to insect stings, Cosmetic allergy, Drug allergy, Acute allergic reaction, Laryngeal edema allergic genesis and background radiation, Food and drug allergy

Composition and form of release

Ointment 1 g

Fluticasone propionate 50 μg

Auxiliary substances: propylene glycol; Sorbitan sesquioleate; Microcrystalline wax; Liquid paraffin

In tubes of 15 g; In a pack of cardboard 1 tuba.

Cream 1 g

Fluticasone propionate 500 μg

Auxiliary substances: liquid paraffin; Isopropyl myristate; Cetostearyl alcohol; Ketomacrogol 1000; Propylene glycol; Imidourea; Sodium phosphate; Citric acid monohydrate; purified water

In tubes of 15 g; In a pack of cardboard 1 tuba.

pharmachologic effect

Pharmacological action - anti-inflammatory, antiallergic, antipruritic.

Has glucocorticoid activity.

Indications

Eczema (atopic, discoid, in children); Knotty pruritis; Psoriasis (excluding common plaque); Neurodermatosis (including simple lichen, red lichen, seborrheic dermatitis); Discoid lupus erythematosus; Red sweats; Generalized erythroderma (as an additional tool for systemic therapy); Insect bites, allergic contact reactions, itching.

Contraindications

Hypersensitivity, acne pink and ordinary, perioral dermatitis, primary viral, fungal and bacterial skin infections, itching of the anogenital area.

Application in pregnancy and lactation

Perhaps, if the expected effect of therapy exceeds the potential risk to the fetus.

Side effects

Allergic contact dermatitis, local allergic reactions: burning and itching (require drug discontinuation), secondary infections. With prolonged use in high doses - local atrophic changes in the skin (thinning, striae, widening of the surface vessels, hypertrichosis, hypopigmentation), systemic absorption with signs of hypercorticism, oppression of adrenal cortex function, relapse, tolerance.

Dosing and Administration

Locally.

Treatment of acute and chronic dermatoses. Ointment or cream is applied a thin layer on the affected skin 1-2 times a day. The course of treatment - 2 weeks.

Reducing the risk of recurrence of the disease. After achieving a therapeutic effect in the acute phase of the disease, the frequency of ointment or cream is reduced: it is recommended to apply the drug once or twice a week without applying an occlusive dressing. Kutiveyt is applied to all previously affected areas of the skin or to areas where a relapse of the disease can be expected.

Precautionary measures

Avoid contact with eyes (local irritation, increased intraocular pressure). Therapy of secondarily infected lesions requires the use of appropriate antibacterial agents, and the appearance of signs of the spread of infection - the cancellation of Kutiveyt. Before applying a new dressing, the skin should be thoroughly processed.

Storage conditions

At a temperature not exceeding 30 ° C.

Keep out of the reach of children.

Shelf life

2 years.

Do not use after the expiry date printed on the package.